Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology
Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase 1/2, Multicenter, First-in-Human, Dose Escalation and Expansion Study Evaluating CHM-029, as Monotherapy and in Combination with Standard Therapies in Participants with Relapsed or Refractory, or Newly Diagnosed Acute Myeloid Leukemia (AML) with NPM1 Mutations, KMT2A or NUP98 Rearrangements
Sponsor Charm Therapeutics Limited
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Sponsor Bristol-Myers Squibb Services Unlimited Company
- Start (EU)
- Latest update
- Estimated end
A Phase 3, Randomized, Double-blind Study of Neoadjuvant Chemotherapy plus Nivolumab versus Neoadjuvant Chemotherapy plus Placebo, followed by Surgical Resection and Adjuvant Treatment with Nivolumab or Placebo for Participants with Resectable Stage II-IIIB Non-small Cell Lung Cancer (CheckMate 77T, CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 77T)
Sponsor Bristol-Myers Squibb Services Unlimited Company
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology?
The 2026-10-09 snapshot links Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology to 3 distinct CTIS trials. Recorded services include Histopathology, Central Pathology Review, Laboratory services, Primary/surrogate endpoint test, Blinded pathology review of renal biopsies. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology?
The most frequently recorded therapeutic areas are Haematological Malignancies, Nephrology, Transplantation. Recorded phases include Phase 1, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology conducted?
The linked trials record locations in 9 countries, including Germany, Spain, France, Netherlands, Belgium. These are trial locations, not confirmed office locations or countries where Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology delivered services.
What can this page tell me about Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Johns Hopkins University School of Medicine, Division of Kidney-Urologic Pathology